Alexander-Bridges, M. and Doan, L. L.
Abstract
Underrepresentation of racial and ethnic minorities in clinical research limits the applicability of trial results to diverse subpopulations. Recognizing an ongoing need to increase participation by minorities, The Endocrine Society established a task force of thought leaders from all stakeholder groups—the pharmaceutical industry, federal agencies, academia, and community groups—to develop a white paper outlining recommendations for meeting this need. The primary goal is to ensure that clinical research supporting the safety and efficacy of pharmaceutical products and the validity of biomarkers used to design therapeutic strategies is based on statistically powered data derived from minority subpopulations. To realize…
| Export/Citation: | EndNote | BibTeX | Dublin Core | ASCII (Chicago style) | HTML Citation | OpenURL | Reference Manager |
| Social Networking: |
| Item Type: | Article |
|---|---|
| Additional Information: | This article is available at the publisher’s Web site. Access to the full text is subject to the publisher’s access restrictions. |
| Uncontrolled Keywords: | racial and ethnic minorities, clinical research |
| Subjects: | Health > Health Equity Health > Pharmacotherapy Health > Policy Research |
| Related URLs: | |
| Depositing User: | Users 141 not found. |
| Date Deposited: | 07 Sep 2011 11:20 |
| Last Modified: | 07 Sep 2011 11:20 |
| Link to this item (URI): | http://health-equity.pitt.edu/id/eprint/3211 |
Actions (login required)
| View Item |
![[feed]](http://health-equity.pitt.edu/images/feed-icon-32x32.png){kind=icon}